跳至主要内容
临床试验/CTRI/2020/02/023472
CTRI/2020/02/023472已完成未知

Estimation of human beta-defensin-1 levels in Gingival Crevicular Fluid using ELISA among smoker and non-smoker patients with chronic periodontitis. - hBD-1, ELISA

Dr Tanya Anand0 个研究点目标入组 72 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Group A ââ?¬â??Non smoker patients
  • a) Patient with age group 30-60 years
  • b) Patients who had never smoked
  • c) Generalized chronic periodontitis (ââ?°Â¥ 30% sites) patients exhibiting mild clinical attachment loss of 1-2mm
  • d) Patients with pocket depth of 4-6mm
  • e) Patients willing to participate in the study.
  • Group B-Smoker patients
  • a) Patients with age group 30-60 years
  • b) Current smoker having ââ?°Â¤ 10 cigarettes/day in past 2 years
  • c) Generalized chronic periodontitis (ââ?°Â¥ 30% sites) patients exhibiting mild clinical attachment loss of 1-2mm
  • d) Patients with pocket depth of 4-6mm.
  • e) Patients willing to participate in the study.

排除标准

  • a) Pregnant women or lactating mothers.
  • b) History of systemic diseases
  • c) Patients with history of periodontal treatment in past 3 months.

研究者

发起方
Dr Tanya Anand

相似试验

Human beta-defensin-1 biomarker levels in smokers... | 临床试验